Nomura Holdings Inc Seagen Inc. Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $8.17 Million - $9.22 Million	42,659 Added 231.33%	61,100 $13 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $2.38 Million - $2.62 Million	12,691 Added 220.71%	18,441 $3.55 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $733,642 - $1.17 Million	5,750 New	5,750 $1.16 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $752,867 - $1.04 Million	-5,475 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $901,349 - $1.16 Million	5,475 New	5,475 $962,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.